Methodological issues in clinical trials of antidepressant medications: Perspectives from psychotherapy outcome research

被引:32
作者
Gaudiano, BA
Herbert, JD
机构
[1] Butler Hosp, Psychosocial Res Program, Providence, RI 02906 USA
[2] Brown Univ, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA
[3] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA
关键词
antidepressants/active placebos; psychotherapy; outcome research; psychotherapy outcome research; depression; randomized controlled trials;
D O I
10.1159/000082022
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Despite their widespread use, the specific efficacy of antidepressant medications has been a source of debate in recent years. Examination of the literature reveals that a significant proportion of the benefit produced in antidepressant trials is duplicated in pill placebo conditions. Furthermore, early trials utilizing active placebos, or medications that mimic the common side effects of antidepressants, showed even smaller differences as compared with active medications. We examine issues surrounding the use of placebo control conditions in antidepressant trials, including the pros and cons of active placebos. We conclude that similar challenges are faced by psychotherapy outcome researchers who have focused more on the separation of specific from nonspecific treatment factors and on the effects of researcher allegiance and patient expectancy on outcome. Within this context, recommendations for improving future antidepressant research are discussed. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 69 条
[1]  
[Anonymous], PLACEBO THEORY RES M
[2]  
[Anonymous], PREVENTION TREATMENT
[3]  
[Anonymous], 2002, Prevention & Treatment, DOI [DOI 10.1037/1522-3736.5.1.525C, 10.1037/1522-3736.5.1.525c]
[4]   Raising questions about antidepressants [J].
Antonuccio, DO ;
Danton, WG ;
DeNelsky, GY ;
Greenberg, RP ;
Gordon, JS .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 1999, 68 (01) :3-14
[5]  
Basoglu M, 1997, ARCH GEN PSYCHIAT, V54, P744
[6]  
Beck, 1979, COGNITIVE THERAPY DE
[7]  
Benedetti F., 2003, PREVENTION TREATMENT, V6, p1a, DOI [DOI 10.1037/1522-3736.6.1.61A, 10.1037/1522-3736.6.1.61a, 10.1037/1522-3736.6.1.a]
[8]   A component analysis of cognitive-behavioral therapy for generalized anxiety disorder and the role of interpersonal problems [J].
Borkovec, TD ;
Newman, MG ;
Pincus, AL ;
Lytle, R .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2002, 70 (02) :288-298
[9]   INERT PLACEBO VERSUS ACTIVE MEDICATION - PATIENT BLINDABILITY IN CLINICAL PHARMACOLOGICAL TRIALS [J].
BYSTRITSKY, A ;
WAIKAR, SV .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1994, 182 (09) :485-487
[10]   Active placebos in antidepressant trials [J].
Cooney, JM .
BRITISH JOURNAL OF PSYCHIATRY, 1998, 172 :541-542